The COVID-19 vaccine: What we know

With approval by the FDA expected within days, officials in New Jersey prepare for rollout of vaccines across the state

By Lilo Stainton, NJSpotlight

As federal experts determined that “known and potential benefits” outweigh the related risks when it comes to Pfizer’s COVID-19 vaccine, New Jersey officials are poised in the coming weeks to launch their part of what is likely the largest immunization campaign in history.

Gov. Phil Murphy said Tuesday that state officials have fine-tuned their vaccine plan and are working with a network of public and private health-care providers and other stakeholders to be ready. They aim to begin immunizing priority individuals within a day or so of a final federal approval, which could come as early as Thursday.

“It’s safe based on everything we know,” Murphy said Tuesday during a public conversation with SkyBridge Capital’s founder and partner Anthony Scaramucci, who briefly served as President Donald Trump’s communication director. (Both Murphy and Scaramucci worked at Goldman Sachs.)


Posted: December 9th, 2020 | Author: | Filed under: COVID-19, New Jersey | Tags: , | Comments Off on The COVID-19 vaccine: What we know

Comments are closed.